- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-mer
- Ligands
- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 36 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.4: 2 residues within 4Å:- Chain A: F.59, N.61
Ligand excluded by PLIPNAG.5: 2 residues within 4Å:- Chain A: N.164, N.165
Ligand excluded by PLIPNAG.6: 3 residues within 4Å:- Chain A: N.234, T.236
- Chain G: E.465
Ligand excluded by PLIPNAG.7: 3 residues within 4Å:- Chain A: N.280, N.282
- Chain G: K.558
Ligand excluded by PLIPNAG.8: 1 residues within 4Å:- Chain A: N.331
Ligand excluded by PLIPNAG.9: 3 residues within 4Å:- Chain A: N.616, T.618, E.619
Ligand excluded by PLIPNAG.10: 2 residues within 4Å:- Chain A: H.655, N.657
Ligand excluded by PLIPNAG.11: 4 residues within 4Å:- Chain A: S.708, N.709, I.1130
- Chain D: D.796
Ligand excluded by PLIPNAG.12: 3 residues within 4Å:- Chain A: N.717, Q.926, Q.1071
Ligand excluded by PLIPNAG.13: 4 residues within 4Å:- Chain A: N.801, S.803, Q.804, N.928
Ligand excluded by PLIPNAG.14: 2 residues within 4Å:- Chain A: A.706, N.1074
Ligand excluded by PLIPNAG.15: 1 residues within 4Å:- Chain A: N.1134
Ligand excluded by PLIPNAG.16: 2 residues within 4Å:- Chain D: F.59, N.61
Ligand excluded by PLIPNAG.17: 2 residues within 4Å:- Chain D: N.164, N.165
Ligand excluded by PLIPNAG.18: 3 residues within 4Å:- Chain A: E.465
- Chain D: N.234, T.236
Ligand excluded by PLIPNAG.19: 3 residues within 4Å:- Chain A: K.558
- Chain D: N.280, N.282
Ligand excluded by PLIPNAG.20: 1 residues within 4Å:- Chain D: N.331
Ligand excluded by PLIPNAG.21: 3 residues within 4Å:- Chain D: N.616, T.618, E.619
Ligand excluded by PLIPNAG.22: 2 residues within 4Å:- Chain D: H.655, N.657
Ligand excluded by PLIPNAG.23: 4 residues within 4Å:- Chain D: S.708, N.709, I.1130
- Chain G: D.796
Ligand excluded by PLIPNAG.24: 3 residues within 4Å:- Chain D: N.717, Q.926, Q.1071
Ligand excluded by PLIPNAG.25: 4 residues within 4Å:- Chain D: N.801, S.803, Q.804, N.928
Ligand excluded by PLIPNAG.26: 3 residues within 4Å:- Chain D: A.706, N.1074
- Chain G: Q.895
Ligand excluded by PLIPNAG.27: 1 residues within 4Å:- Chain D: N.1134
Ligand excluded by PLIPNAG.28: 2 residues within 4Å:- Chain G: F.59, N.61
Ligand excluded by PLIPNAG.29: 2 residues within 4Å:- Chain G: N.164, N.165
Ligand excluded by PLIPNAG.30: 3 residues within 4Å:- Chain D: E.465
- Chain G: N.234, T.236
Ligand excluded by PLIPNAG.31: 3 residues within 4Å:- Chain D: K.558
- Chain G: N.280, N.282
Ligand excluded by PLIPNAG.32: 1 residues within 4Å:- Chain G: N.331
Ligand excluded by PLIPNAG.33: 3 residues within 4Å:- Chain G: N.616, T.618, E.619
Ligand excluded by PLIPNAG.34: 2 residues within 4Å:- Chain G: H.655, N.657
Ligand excluded by PLIPNAG.35: 4 residues within 4Å:- Chain A: D.796
- Chain G: S.708, N.709, I.1130
Ligand excluded by PLIPNAG.36: 3 residues within 4Å:- Chain G: N.717, Q.926, Q.1071
Ligand excluded by PLIPNAG.37: 3 residues within 4Å:- Chain G: N.801, S.803, N.928
Ligand excluded by PLIPNAG.38: 2 residues within 4Å:- Chain G: A.706, N.1074
Ligand excluded by PLIPNAG.39: 1 residues within 4Å:- Chain G: N.1134
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Beaudoin-Bussieres, G. et al., A Fc-enhanced NTD-binding non-neutralizing antibody delays virus spread and synergizes with a nAb to protect mice from lethal SARS-CoV-2 infection. Cell Rep (2022)
- Release Date
- 2022-04-20
- Peptides
- Spike glycoprotein: ADG
CV3-13 Fab heavy chain: BEH
CV3-13 Fab light chain: CFI - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AD
BG
CB
HE
DH
JC
LF
EI
K
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-mer
- Ligands
- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 36 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Beaudoin-Bussieres, G. et al., A Fc-enhanced NTD-binding non-neutralizing antibody delays virus spread and synergizes with a nAb to protect mice from lethal SARS-CoV-2 infection. Cell Rep (2022)
- Release Date
- 2022-04-20
- Peptides
- Spike glycoprotein: ADG
CV3-13 Fab heavy chain: BEH
CV3-13 Fab light chain: CFI - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AD
BG
CB
HE
DH
JC
LF
EI
K